SINOMED
@sinomed.com
PRODUCTS Drug Coated Coronary Stent System HT SUPREME® The Healing-Targeted Drug Eluting Stent is designed specifically to allow natural healing through elution kinetics, biodegradable polymer and specialized coating. This new class of DES focused on rapid healing allows a quicker
SINOMED's Company Logos
SINOMED's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#005BAC
Endeavour
0, 91, 172
208, 100, 34
100, 47, 0, 33
#2E507D
Chambray
46, 80, 125
214, 46, 34
63, 36, 0, 51
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
About SINOMED
SINOMED is a global medical technology company focused on patient-centered innovation in interventional medicine. Founded in 2007 to improve the common coronary stent, it has since expanded its portfolio and works to combine human ingenuity with technology to address cardiovascular disease. The company is publicly traded on Shanghai’s STAR Market under stock code 688108 and is described as a leader in China’s coronary stent market.
Its products and solutions address coronary, neurovascular and structural heart conditions. Offerings include the HT SUPREME drug-coated coronary stent system, designed to support natural vessel healing; the NOVA NEO intracranial drug-eluting stent system, developed for neuro-interventional treatment; and the ACCUFIT transapical mitral valve replacement system, designed for minimally invasive procedures. SINOMED also invests in a clinical program, conducting trials to support device approvals, evaluate performance across clinical scenarios and identify ways to improve patient outcomes. Through its medical devices and research, the company aims to help more patients benefit from advances in healthcare and improve quality of life.
Brand industry
Health
Company type
Suggest company type
Year founded
Suggest founded year
Company size
Suggest company size
